SkinBioTherapeutics (SBTX)

Sector:

Pharma and Biotech

Index:

FTSE AIM All-Share

16.44p
   
  • Change Today:
    -0.36p
  • 52 Week High: 26.10
  • 52 Week Low: 8.50
  • Currency: UK Pounds
  • Shares Issued: 258.78m
  • Volume: 397,651
  • Market Cap: £42.54m
  • Beta: 0.01

SBTX Overview

SkinBioTherapeutics is a life science company focused on skin health. The Company’s proprietary platform technology, SkinBiotix®, is based upon discoveries made by CSO Dr. Catherine O’Neill and Professor Andrew McBain at The University of Manchester.

Key Personnel

CEO: Stuart Ashman
CFO: Manprit Singh Randhawa
Executive Director: Simon Hewitson
Group Finance Director: Emily Bertram
Independent Non-Executive Director: Catherine Denise Prescott
Non-Executive Chairman: Martin Braddock Hunt
Non-Executive Dir: Danielle Bekker

Contact Details

Address: The Core, Bath Lane, Newcastle Helix, Newcastle upon Tyne, United Kingdom, NE4 5TF
Phone: +44 191 495 7325
Website: http://www.skinbiotherapeutics.com

Listings

Sector: Pharma and Biotech(LSE)
Index: FTSE AIM All-Share
ISIN: GB00BF33H870

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

 

SBTX Market Data

Currency UK Pounds
Share Price 16.44p
Change Today -0.36p
% Change -2.16 %
52 Week High 26.10
52 Week Low 8.50
Volume 397,651
Shares Issued 258.78m
Market Cap £42.54m
Beta 0.01

SBTX Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
70.51% below the market average70.51% below the market average70.51% below the market average70.51% below the market average70.51% below the market average
86.96% below the sector average86.96% below the sector average86.96% below the sector average86.96% below the sector average86.96% below the sector average
Price Trend
64.49% above the market average64.49% above the market average64.49% above the market average64.49% above the market average64.49% above the market average
78.26% above the sector average78.26% above the sector average78.26% above the sector average78.26% above the sector average78.26% above the sector average
Income Not Available
Growth
48.70% above the market average48.70% above the market average48.70% above the market average48.70% above the market average48.70% above the market average
61.29% above the sector average61.29% above the sector average61.29% above the sector average61.29% above the sector average61.29% above the sector average

SBTX Dividends

No dividends found

Trades for 30-Jun-2025

Time Volume / Share Price
09:16 9,146 @ 16.40p
08:58 1,474 @ 16.45p
08:56 64,000 @ 16.35p
08:39 10,050 @ 16.45p
08:37 15,000 @ 16.50p

SBTX Key Personnel

CEO Stuart Ashman
CFO Manprit Singh Randhawa

Top of Page